妊娠中の反応性低血糖症と不良妊娠結果: 系統的レビューとメタ解析
Muhammad Pradhiki Mahindra1, Michelle Jie2, Muhammad Pradhika Mapindra3
1EGA Institute for Women's Health, University College London, London, UK. muhammad.mahindra.21@ucl.ac.uk.
BMC pregnancy and childbirth
|August 26, 2025
まとめ
妊娠中の反応性低血糖症 (GRH) は,妊娠年齢に比べて小さい,低出生体重,胎児の成長制限,およびNICU入院のリスクを高めます. GRHの診断基準を確立するためにさらなる研究が必要である.
科学分野:
- 産婦人科
- 内分泌学
- 新生児科
背景:
- 反応性低血糖症は,血糖の負荷後に血糖が低下し,妊娠に影響を与える可能性があります.
- 妊娠中の反応性低血糖症 (GRH) は,妊娠中の不良結果との関連性についてさらなる調査が必要である.
研究 の 目的:
- 妊娠中の反応性低血糖症 (GRH) と妊娠中の不良結果との関連を判断する.
- 妊娠中の糖尿病とグルコース代謝障害に関連するリスクを調査する.
主な方法:
- 4つのデータベース (Medline,Embase,Web of Science,Maternity & Infant care) の体系的なレビューとメタ分析を行いました.
- 114, 148人の参加者を含む30件の研究 (18, 878人がGRH).
- SGA,FGR,LBW,NICU入院,ポリヒドラムニオスのようなアウトカムの分析.
主要な成果:
- GRHはSGA (RR=1. 49),LBW (RR=1. 35),FGR (RR=1.21) とNICU入院 (RR=1.23) のリスク増加と関連していました.
- サブグループ分析では,負荷後のグルコース< 3 mmol/ lで診断されたGRHは,NICU入院リスクの増加を示した (RR=3. 39).
- GTT後のGRHは,ポリヒドラムニオスの高リスク (RR=1. 93) とSGA (RR=1. 90) と関連していました.
結論:
- GRHは,日常的に診断されないが,SGA,FGR,およびNICU入院などの不良胎児と関連している.
- グルコース耐性検査で特定されたGRHは,多水性肌痛のリスクの増加と関連しています.
- GRHの診断基準を定義し,他のグルコース代謝障害との関連を調べるためにさらなる研究が必要である.
関連する概念動画
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Hypoglycemia and Glucagon
334
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
334
Teratogenicity
2.7K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones
291
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
291
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174


